Skip to main content

Table 1 Demographic and clinical characteristics of 729 patients hospitalized for COVID-19 suspicion in Niger

From: Clinical features and predictors of mortality among hospitalized patients with COVID-19 in Niger

Variables

Alive COVID-19 (−)

N = 242 (33.20%)

Alive COVID-19 (+)

N = 402 (55.14%)

Dead

N = 85 (11.66%)

All

N = 729

P-values

Age (median/IQR)

40 (26.5–60)

45 (29–59)

65 (29–59)

46 (30–61)

0.0001

Age groups

     

 < 15 years

16 (6.67)

8 (2.00)

2 (2.35)

26 (3.58)

 < 0.0001

15–34 years

87 (36.25)

125 (31.17)

5 (5.88)

217 (29.89)

 

35–59 years

71 (29.58)

174 (43.39)

23 (27.06)

268 (36.91)

 

 ≥ 60 years

66 (27.50)

94 (23.44)

55 (64.71)

215 (29.61)

 

Sex

     

Male

171 (70.66)

296 (73.63)

57 (67.06)

524 (71.88)

0.401

Profession

     

Student

7 (7.45)

41 (10.93)

0 (0.00)

48 (8.76)

 < 0.0001

Public Servant/Administration

6 (6.38)

89 (23.73)

23 (29.11)

118 (13.69)

 

Housekeeper/none

25 (26.60)

30 (8.00)

20 (25.32)

75 (13.69)

 

Private

48 (51.06)

150 (40.00)

34 (43.04)

232 (42.34)

 

Health workers

8 (8.51)

65 (17.33)

2 (2.53)

75 (13.69)

 

Travel last 14 days

     

Yes

24 (10.57)

91 (22.64)

5 (5.88)

120 (16.81)

 < 0.0001

Detected at entry port

     

Yes

0 (0.00)

62 (15.42)

0 (0.00)

62 (12.73)

 < 0.0001

Contact of confirmed case

     

Yes

5 (2.21)

107 (26.62)

13 (15.48)

125 (17.56)

 < 0.0001

Visited hospital last 14 days

     

Yes

40 (18.43)

83 (20.65)

19 (22.62)

142 (20.20)

0.66

History of comorbidity

     

Chronic Respiratory Diseases

8 (47.06)

14 (63.64)

5 (71.43)

27 (58.70)

0.44

CVD/HPT

12 (57.14)

52 (86.67)

32 (94.12)

96 (83.48)

0.001

Diabetes

9 (50.00)

29 (78.38)

20 (90.91)

58 (75.32)

0.01

Obesity

0 (0.00)

0 (0.00)

2 (50.00)

2 (9.52)

0.029

HIV (+)

0 (0.00)

3 (27.27)

0 (0.00)

3 (13.64)

0.29

Tuberculosis

2 (18.18)

1 (11.1)

0 (0.00)

3 (13.64)

0.76

CKD

4 (30.77)

0 (0.00)

1 (33.33)

5 (20.83)

0.21

Any cancer

0 (0.00)

2 (20.00)

2 (50.00)

4 (17.39)

0.1

Any comorbidity

46 (21.10)

119 (29.60)

53 (63.10)

218 (30.97)

 < 0.0001

 ≥ 2 Comorbidities

6 (40.00)

25 (75.76)

19 (90.48)

50 (72.46)

0.004

Time symptoms-consultation (mean ± SD)

3.5 (5.81)

2.42 (4.23)

2.69 (3.51)

2.76 (4.65)

 < 0.0001

Symptoms

     

Fever/chills

4 (1.65)

118 (29.35)

43 (50.59)

165 (22.63)

 < 0.0001

Sore throat

3 (1.24)

55 (13.68)

7 (8.24)

65 (8.29)

 < 0.0001

Cough

4 (1.65)

136 (33.83)

36 (42.35)

176 (24.14)

 < 0.0001

Rhinorrhea

0 (0.00)

38 (9.45)

7 (8.24)

45 (6.17)

 < 0.0001

Shortness of breath

2 (0.83)

73 (18.16)

43 (50.59)

118 (16.19)

 < 0.0001

Anosmia/Ageusia

7 (5.79)

6 (4.03)

3 (8.33)

16 (5.23)

0.5

Thoracic pain

35 (28.93)

27 (18.24)

5 (13.89)

67 (21.97)

0.05

Digestive signs

30 (24.79)

32 (21.62)

7 (19.44)

69 (22.62)

0.73

Headache

38 (31.40)

36 (24.32)

6 (16.67)

80 (26.23)

0.16

Asthenia/fatigue

35 (28.93)

25 (16.89)

8 (22.22)

68 (22.30)

0.06

Musculoskeletal pain

7 (5.79)

13 (8.78)

2 (5.56)

22 (7.21)

0.59

Time hospitalization-discharge/death (mean ± SD)

12 (0.10)

14.31 (6.61)

4.74 (5.11)

12.6 (7.33)

 < 0.0001

  1. All values are count and percentage unless otherwise indicated
  2. SD, standard deviation; IQR, interquartile range; CVD/HPT, cardiovascular diseases/hypertension; CKD, chronic kidney diseases; HIV, human immunodeficiency virus